2nd TCR-based Therapies Summit
Evvnt Promotion / evvnt
08.06.2021 - 10.06.2021 Virtual
Time: 09:30 to 16:15
Temas de la conferencia
Running digitally for 2021, the 2nd TCR-based Therapies Summit is the leading industry-focused meeting dedicated to supercharging the expanded TCR repertoire through enhanced target specificity, density and binding affinity for solid tumor indications.
Running digitally for 2021, the 2nd TCR-based Therapies Summit is the leading industry-focused meeting dedicated to supercharging the expanded TCR repertoire through enhanced target specificity, density and binding affinity for solid tumor indications.
Organizador profesional (PCO)
Hanson Wade
Hanson Wade
Observaciones
Brochure: https://go.evvnt.com/730790-3?pid=4832
Speakers: Hans-Peter Gerber SVP and CSO 3T Biosciences, Joseph Dukes VP Translational Sciences Enara Bio, Leah Sibener Co-founder, Head of Therapeutic Discovery 3T Bioscience, and more.
Brochure: https://go.evvnt.com/730790-3?pid=4832
Speakers: Hans-Peter Gerber SVP and CSO 3T Biosciences, Joseph Dukes VP Translational Sciences Enara Bio, Leah Sibener Co-founder, Head of Therapeutic Discovery 3T Bioscience, and more.
Información e inscripción:
https://go.evvnt.com/730790-2?pid=4832
Mr. Customer Service
Medicina General
Idioma
Inglés
Inglés
Cuota del Congreso
Conference Only: USD 2499.00, Conference + 2 Workshops: USD 3297.00, Conference + Focus Day: USD 3297.00
Conference Only: USD 2499.00, Conference + 2 Workshops: USD 3297.00, Conference + Focus Day: USD 3297.00
Cantacto organizador
83 Great Titchfield Street
W1W 6RH London
United Kingdom
83 Great Titchfield Street
W1W 6RH London
United Kingdom
"Going International fomenta el acceso a la educación y a la formación continua independientemente de fronteras sociales, geográficas y nacionales."
